Eton Pharmaceuticals (ETON) Net Equity Issued and Repurchased (2019 - 2020)
Eton Pharmaceuticals' (ETON) quarterly Net Equity Issued and Repurchased came in at $21.0 million in Q4 2020, up 171.09% quarter-over-quarter from $7.8 million in Q1 2020.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Net Equity Issued and Repurchased (2019 - 2020) Analysis & Trends
Eton Pharmaceuticals has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $21.0 million for Q4 2020.
- In Q4 2020, Net Equity Issued and Repurchased changed N/A year-over-year to $21.0 million; the TTM figure through Dec 2020 stood at $28.8 million (changed N/A YoY), while the FY2020 annual figure was $28.8 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at $21.0 million for Q4 2020 at Eton Pharmaceuticals, up from $7.8 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $21.0 million in Q4 2020 to a low of $77000.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 141.90 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 21.03 Mn |
| Mar 31, 2020 | 7.76 Mn |
| Sep 30, 2019 | 77,000.00 |